Sirio Pharma Co., Ltd. (SHE:300791)

China flag China · Delayed Price · Currency is CNY
24.96
+0.02 (0.08%)
Jan 23, 2026, 3:04 PM CST
30.94%
Market Cap7.64B
Revenue (ttm)4.45B
Net Income (ttm)345.53M
Shares Out305.96M
EPS (ttm)1.13
PE Ratio22.04
Forward PE22.75
Dividend0.50 (2.00%)
Ex-Dividend DateMay 27, 2025
Volume2,416,506
Average Volume3,675,267
Open25.18
Previous Close24.94
Day's Range24.67 - 25.18
52-Week Range16.32 - 28.19
Beta0.46
RSI51.97
Earnings DateApr 24, 2026

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China. [Read more]

Founded 1993
Employees 2,776
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300791
Full Company Profile

Financial Performance

In 2024, Sirio Pharma's revenue was 4.21 billion, an increase of 17.56% compared to the previous year's 3.58 billion. Earnings were 325.06 million, an increase of 15.66%.

Financial Statements